Page 498 - Read Online
P. 498

Zein et al. Plast Aesthet Res 2020;7:44  I  http://dx.doi.org/10.20517/2347-9264.2020.133                                        Page 7 of 10

               is therefore important to select a product with low water affinity such as Restylane-L (Galderma, Lausanne,
               Switzerland).


               Tyndall effect
               The Tyndall effect is characterized by a blue-grey discoloration of filler placed superficially under the skin.
               This occurs primarily in the tear trough region where there is minimal subcutaneous fat and the overlying
               skin is very thin. The phenomenon is due to the scattering of blue light as it passes through small particles
               in suspension [44,45] . As all fillers are similarly prone to this complication, the primary preventative measure
               is deep injection. Belotero Balance (Merz, Frankfurt, Germany) is made with varying particle sizes, a
               product characteristic thought to decrease the chances of the Tyndall effect.


               OTHER COMPLICATIONS
               Granulomas
               Granulomas may appear anywhere from 6 to 24 months after injection, and is estimated to occur in 0.1%-1%
                        [46]
               of patients . Presentation usually consists of a constellation of swelling, tenderness, erythema and possible
               suppuration [19,47] . The foreign body reaction results in prolonged inflammation that results in the formation
                                                                                [48]
               of a nodule comprised of macrophages producing inflammatory products . HA fillers reinforced with
                                                                                                     [49]
               hydroxyethyl‐methacrylate fragments have been associated with late-onset granuloma formation . It
               is postulated that impurities and surface irregularities associated with formulations containing particles
               < 20 µm in size, are phagocytosed which propagates granuloma formation [47,50-52] . Granulomas typically
               resolve within two years without the need for intervention, but if the lesion persists can be treated with
               intralesional corticosteroids or surgical excision. Supplemental laser resurfacing or dermabrasion can help
                                                   [53]
               improve superficial surface irregularities . Attempt at dissolving the granulomas with hyaluronidase is
               also a good option.

               Infections
               Infections, while rare, can present in a variety of forms, ranging from erythematous nodules to abscesses.
               The most common culprits are usually bacterial skin flora (Streptococcus pyogenes and Staphylococcus
               aureus), or in some cases herpes simplex virus [18,48,54] . In some cases, latent infections or atypical bacteria
                                                 [55]
               can be explained by biofilm formation . In the event of an abscess, incision and drainage is indicated
               followed by empiric antibiotics to cover the previously mentioned bacteria. Prophylaxis for herpes simplex
               infections is indicated for patients with a history of cold sore outbreaks.

               CONCLUSION
               With the growing number of filler injections used, awareness and prevention of ocular and facial
               complications is paramount. While the majority are self-resolving, such as ecchymoses at the injection
               site, ocular complications such as irreversible blindness and orbital and ocular ischemia are detrimental
               to patients’ visual prognosis and general quality of life. Through a strong grasp of the local anatomy,
               periodicity and presentation of complications, safe technique and knowledge of the available formulations
               on the market, these adverse events can be mitigated or prevented completely.

               DECLARATIONS
               Authors’ contributions
               Conceptualization, writing, and editing of this manuscript: Zein M, Tie-Shue R, Pirakitikulr N, Lee WW

               Availability of data and materials
               Not applicable.
   493   494   495   496   497   498   499   500   501   502   503